Publication |
Data |
|
Fish |
Anatomy
|
Lin et al., 2021
|
Fig. 1
|
|
cftrscu102/scu102
|
|
|
Fig. S1
|
|
cftrscu102/scu102
|
|
|
Fig. S2
|
|
cftrscu102/scu102
|
|
Cafora et al., 2020
|
Fig. 1
|
|
AB + MO1-cftr + MO2-cftr
|
|
Liu et al., 2020
|
Fig. 1
|
|
cftrscu101/scu101
|
- atrium dilated, abnormal
- heart bmp4 expression decreased distribution, abnormal
- heart has2 expression decreased distribution, abnormal
- heart contraction decreased rate of occurrence, abnormal
- heart dysplastic, abnormal
- heart edematous, abnormal
- heart looping process quality, abnormal
- lateral mesoderm nkx2.5 expression decreased distribution, abnormal
- whole organism bmp4 expression decreased amount, abnormal
- whole organism has2 expression decreased amount, abnormal
- whole organism nkx2.5 expression decreased amount, abnormal
|
|
Fig. 3
|
|
cftrscu101/scu101
|
- whole organism atp2a2a expression decreased amount, abnormal
- whole organism cacna2d2a expression decreased amount, abnormal
- whole organism hip1ra expression decreased amount, abnormal
- whole organism itga10 expression decreased amount, abnormal
- whole organism itgb1b.1 expression increased amount, abnormal
- whole organism itgbl1 expression decreased amount, abnormal
- whole organism mamdc2b expression increased amount, abnormal
- whole organism si:ch211-211k8.4 expression decreased amount, abnormal
- whole organism smyhc2 expression increased amount, abnormal
- whole organism tpm4b expression increased amount, abnormal
|
|
Fig. 4
|
|
cftrscu101/scu101
|
|
Liu et al., 2020
|
Fig. 1
|
|
cftrscu102/scu102 (AB)
|
|
|
Fig. 2
|
|
cftrscu102/scu102 (AB)
|
|
|
Fig. 3
|
|
cftrscu102/scu102 (AB)
|
|
Bernut et al., 2019
|
Fig. S3
|
|
i114Tg + MO7-cftr
|
|
Cafora et al., 2019
|
Fig. 2
|
|
AB + MO1-cftr + MO2-cftr
|
|
|
Fig. 4
|
|
AB + MO1-cftr + MO2-cftr
|
|
Liao et al., 2018
|
Fig. 1
|
|
cftrscu101/scu101 (AB)
|
|
|
Fig. 2
|
|
cftrscu101/scu101 (AB)
|
|
|
Fig. 4
|
|
cftrscu101/scu101 (AB)
|
|
|
Fig. 5
|
|
cftrscu101/scu101 (AB)
|
|
Sun et al., 2018
|
Fig. 1
|
|
cftrscu102/+
|
|
|
Fig. 2
|
|
cftrscu102/+
|
- common myeloid progenitor myb expression decreased amount, abnormal
- common myeloid progenitor runx1 expression decreased amount, abnormal
- erythroid lineage cell hbbe3 expression decreased amount, abnormal
- intermediate cell mass of mesoderm hbbe3 expression decreased amount, abnormal
- intermediate cell mass of mesoderm myb expression decreased amount, abnormal
- intermediate cell mass of mesoderm runx1 expression decreased amount, abnormal
- lateral plate mesoderm gata1a expression decreased amount, abnormal
- lateral plate mesoderm gata2a expression decreased amount, abnormal
- lateral plate mesoderm lmo2 expression decreased amount, abnormal
- lateral plate mesoderm tal1 expression decreased amount, abnormal
- myeloid lineage restricted progenitor cell spi1b expression decreased amount, abnormal
|
|
Fig. 3
|
|
cftrscu102/+
, 
AB + MO2-cftr
|
|
|
Fig. S10
|
|
AB + MO2-cftr
|
- common myeloid progenitor myb expression decreased amount, abnormal
- common myeloid progenitor runx1 expression decreased amount, abnormal
- erythroid lineage cell hbbe3 expression decreased amount, abnormal
- intermediate cell mass of mesoderm hbbe3 expression decreased amount, abnormal
- intermediate cell mass of mesoderm myb expression decreased amount, abnormal
- intermediate cell mass of mesoderm runx1 expression decreased amount, abnormal
- lateral plate mesoderm gata1a expression decreased amount, abnormal
- lateral plate mesoderm gata2a expression decreased amount, abnormal
- lateral plate mesoderm lmo2 expression decreased amount, abnormal
- lateral plate mesoderm tal1 expression decreased amount, abnormal
- myeloid lineage restricted progenitor cell spi1b expression decreased amount, abnormal
|
|
Fig. S12
|
|
AB + MO2-cftr
|
|
|
Fig. S14
|
|
AB + MO2-cftr
|
|
|
Fig. S16
|
|
cftrscu102/+
|
|
|
Fig. S18
|
|
cftrscu102/+
|
|
|
Fig. S6
|
|
cftrscu102/+
, 
AB + MO2-cftr
|
|
|
Fig. S7
|
|
AB + MO2-cftr
, 
AB + MO6-cftr
|
|
Ji et al., 2016
|
Fig. 7
|
|
cftrpd1048/pd1048 (AB/TU)
|
|
Delaspre et al., 2015
|
Fig. 7
|
|
cftrpd1049/pd1049
|
|
|
Fig. S5
|
|
cftrpd1049/pd1049
|
|
Navis et al., 2015
|
Fig. 4
|
|
cftrpd1049/pd1049; gz15Tg
|
|
|
Fig. 5
|
|
cftrpd1049/pd1049 (AB)
, 
cftrpd1049/pd1049; gz15Tg; m1018Tg
|
- exocrine pancreas central region lacks all parts of type pancreatic acinar cell, abnormal
- exocrine pancreas degenerate, abnormal
- exocrine pancreas fibrillary, abnormal
- islet decreased size, abnormal
- islet disorganized, abnormal
- islet increased amount, abnormal
- pancreas degenerate, abnormal
- pancreas morphology, abnormal
- pancreatic acinar cell decreased amount, abnormal
- pancreatic duct dilated, abnormal
- pancreatic duct obstructed, abnormal
|
|
Fig. 6
|
|
cftrpd1049/pd1049; gz15Tg
, 
cftrpd1049/pd1049; nz50Tg
|
|
Navis et al., 2013
|
Fig. 2
|
|
cftrpd1049/pd1049; gz15Tg
, 
cftrpd1049/pd1049
|
|
|
Fig. 3
|
|
cftrpd1050/pd1050
, 
cftrpd1048/pd1048
, 
cftrpd1048/pd1048; s870Tg
, 
cftrpd1049/pd1049
, 
cftrpd1049/pd1049; s870Tg
|
|
|
Fig. 8
|
|
cftrpd1049/pd1049
|
|
Phennicie et al., 2010
|
Fig. 2
|
|
AB + MO1-cftr + MO2-cftr
|
|